Mohawk Industries
MHK NYSE Home Furnishings Financials FY2016βFY2025
Mohawk Industries' revenue fell 0.5% to $10.8 billion in fiscal 2025. Its operating margin was 4.5%, down from 6.4% a year earlier. Free cash flow was $616 million, down 9.3%. It paid out $150 million in dividends and buybacks, 24% of free cash flow. The diluted share count fell 1.9%.
What Mohawk Industries does
No business description yet.
- Legal name
- MOHAWK INDUSTRIES, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000851968-26-000011
0000851968
Revenue and margins
Mohawk Industries had $10.8B of revenue in fiscal 2025, down 0.5% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β7.9% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $616M in fiscal 2025, 5.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Mohawk Industries returned $150M to shareholders in fiscal 2025, 24% of free cash flow. The diluted share count fell 1.9%.
Value Mohawk Industries yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.3B and divides by 62.4M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 16.5x Β· peers 15.1x Β· sector 17.9x.
Balance sheet
Cash, debt and the ratios that show how comfortably Mohawk Industries can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $592M | $668M | $643M | $667M | $856M |
| Debt incl. finance leases | $2.4B | $2.9B | $2.8B | $2.3B | $2.1B |
| Net debt / EBITDA | 0.9x | 2.6x | 6.3x | 1.3x | 1.1x |
| Debt / equity | 0.3x | 0.4x | 0.4x | 0.3x | 0.3x |
| Interest coverage | 23.3x | 4.7x | β3.8x | 14.3x | 27.5x |
| Current ratio | 1.8x | 1.9x | 1.8x | 2.0x | 2.2x |
| Quick ratio | 1.0x | 1.0x | 1.0x | 1.1x | 1.2x |
| Total assets | $14.2B | $14.1B | $13.5B | $12.7B | $13.7B |
| Total liabilities | $5.8B | $6.1B | $5.9B | $5.2B | $5.3B |
| Shareholders' equity | $8.4B | $8.0B | $7.6B | $7.5B | $8.4B |
| Net debt (β = net cash) | $1.8B | $2.2B | $2.1B | $1.7B | $1.3B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$24.9M
4 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | Suzanne L HelenPossible Member of Group | Sold | 800 | $125.62 | $0.1M | Form 4 |
| Sep 16, 2026 | Jeffrey S LorberbaumChief Executive Officer, Director, 10% owner | Sold | 11,400 | $128.21 | $1.5M | Form 4 |
| Sep 15, 2026 | Jeffrey S LorberbaumChief Executive Officer, Director, 10% owner | Sold | 11,475 | $128.97 | $1.5M | Form 4 |
| Sep 14, 2026 | Jeffrey S LorberbaumChief Executive Officer, Director, 10% owner | Sold | 45,750 | $127.18 | $5.8M | Form 4 |
| Sep 11, 2026 | Jeffrey S LorberbaumChief Executive Officer, Director, 10% owner | Sold | 22,875 | $126.84 | $2.9M | Form 4 |
| Aug 14, 2026 | Suzanne L HelenPossible Member of Group | Sold | 1,000 | $139.48 | $0.1M | Form 4 |
| Aug 5, 2026 | Bernard ThiersDirector | Sold | 13,393 | $134.98 | $1.8M | Form 4 |
| Aug 3, 2026 | David Lee ReppSvp-cao & Corporate Controller | Sold | 225 | $130.59 | $0.0M | Form 4 |
| Aug 3, 2026 | Jeffrey S LorberbaumChief Executive Officer, Director, 10% owner | Sold | 59,078 | $131.59 | $7.8M | Form 4 |
| Aug 3, 2026 | Suzanne L HelenPossible Member of Group | Sold | 7,000 | $131.52 | $0.9M | Form 4 |
| Jun 18, 2026 | Suzanne L HelenPossible Member of Group | Sold | 16,600 | $112.97 | $1.9M | Form 4 |
| Jun 17, 2026 | Suzanne L HelenPossible Member of Group | Sold | 5,000 | $111.92 | $0.6M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 4 / 9 | 9 / 9 | 7 / 9 |
| Accruals ratio | β12.9% | β4.7% | β5.2% |
| Altman Z'' | 4.07 | 5.17 | 5.24 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Mohawk Industries MHK | $7.6B | β0.5% | 4.5% | 5.7% | 4.1% | 16.5x | 7 | |
| Somnigroup International SGI | $13.7B | 51.6% | 10.1% | 8.5% | 11.7% | 25.8x | 6 | Compare β |
| Leggett & Platt LEG | β | β7.5% | β | 6.9% | β | β | β | Compare β |
| La-Z-Boy LZB | $1.2B | 0.8% | 6.1% | 6.0% | 13.1% | 15.1x | 7 | Compare β |
| Autoliv ALV | $8.4B | 4.1% | 10.1% | 6.6% | 20.3% | 13.8x | 8 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $9.0B | $9.5B | $10.0B | $10.0B | $9.6B | $11.2B | $11.7B | $11.1B | $10.8B | $10.8B |
| Gross profit | $2.8B | $3.0B | $2.8B | $2.7B | $2.4B | $3.3B | $2.9B | $2.7B | $2.7B | $2.6B |
| Operating income | $1.3B | $1.4B | $1.1B | $827M | $636M | $1.3B | $244M | β$292M | $694M | $490M |
| Interest expense | $40.5M | $31.1M | $38.8M | $41.3M | $52.4M | $57.3M | $51.9M | $77.5M | $48.5M | $17.8M |
| Pretax income | $1.2B | $1.3B | $1.0B | $750M | $584M | $1.3B | $184M | β$364M | $643M | $469M |
| Income tax | $308M | $343M | $184M | $5.0M | $68.6M | $256M | $158M | $84.9M | $128M | $98.8M |
| Net income | $930M | $972M | $862M | $744M | $516M | $1.0B | $25.2M | β$449M | $515M | $370M |
| Diluted EPS | $12.48 | $12.98 | $11.47 | $10.30 | $7.22 | $14.94 | $0.39 | β$7.05 | $8.09 | $5.93 |
| Diluted shares | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.06B | 0.06B | 0.06B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | $1.3B | $1.2B | $1.2B | $1.4B | $1.8B | $1.3B | $669M | $1.3B | $1.1B | $1.1B |
| Capital expenditure | $672M | $906M | $794M | $546M | $426M | $676M | $581M | $613M | $454M | $440M |
| Free cash flow | $673M | $288M | $387M | $873M | $1.3B | $633M | $88.5M | $716M | $680M | $616M |
| Depreciation and amortization | $410M | $447M | $522M | $577M | $608M | $592M | $596M | $630M | $638M | $653M |
| Stock-based compensation | $35.1M | $36.3M | $31.4M | $23.6M | $19.7M | $25.7M | $22.4M | $20.9M | $27.5M | $30.0M |
| Acquisitions | $0.0M | $251M | $569M | $81.1M | $0.0M | $124M | $210M | $515M | $0.0M | $6.9M |
| Share buybacks | $0.0M | $0.0M | $274M | $100M | $189M | $900M | $308M | $0.0M | $163M | $150M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $0.0M | $274M | $100M | $189M | $900M | $308M | $0.0M | $163M | $150M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $122M | $84.9M | $119M | $177M | $1.3B | $592M | $668M | $643M | $667M | $856M |
| Total debt | $2.5B | $2.8B | $3.3B | $2.6B | $2.7B | $2.3B | $2.8B | $2.7B | $2.2B | $2.0B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $30.0M | $46.1M | $47.9M | $52.0M | $71.2M | $82.2M | $82.8M |
| Current assets | $3.5B | $4.1B | $4.5B | $4.4B | $5.4B | $5.2B | $5.9B | $5.6B | $5.5B | $6.0B |
| Current liabilities | $2.7B | $2.7B | $3.3B | $2.7B | $2.4B | $2.9B | $3.1B | $3.1B | $2.7B | $2.7B |
| Inventory | $1.7B | $1.9B | $2.3B | $2.3B | $1.9B | $2.4B | $2.8B | $2.6B | $2.5B | $2.7B |
| Property and equipment, net | $3.4B | $4.3B | $4.7B | $4.7B | $4.6B | $4.6B | $4.7B | $5.0B | $4.6B | $4.8B |
| Total assets | $10.2B | $12.1B | $13.1B | $13.4B | $14.3B | $14.2B | $14.1B | $13.5B | $12.7B | $13.7B |
| Total liabilities | $4.4B | $5.0B | $5.7B | $5.3B | $5.8B | $5.8B | $6.1B | $5.9B | $5.2B | $5.3B |
| Shareholders' equity | $5.8B | $7.1B | $7.4B | $8.1B | $8.5B | $8.4B | $8.0B | $7.6B | $7.5B | $8.4B |
| Margins | ||||||||||
| Gross margin | 31.4% | 31.6% | 28.4% | 26.8% | 25.5% | 29.2% | 25.1% | 24.3% | 24.8% | 23.9% |
| Operating margin | 14.3% | 14.3% | 11.0% | 8.3% | 6.7% | 11.9% | 2.1% | β2.6% | 6.4% | 4.5% |
| EBITDA margin | 18.9% | 19.0% | 16.2% | 14.1% | 13.0% | 17.2% | 7.2% | 3.0% | 12.3% | 10.6% |
| Net margin | 10.4% | 10.2% | 8.6% | 7.5% | 5.4% | 9.2% | 0.2% | β4.0% | 4.8% | 3.4% |
| FCF margin | 7.5% | 3.0% | 3.9% | 8.8% | 14.1% | 5.7% | 0.8% | 6.4% | 6.3% | 5.7% |
| Returns | ||||||||||
| Return on capital | 11.9% | 11.2% | 8.9% | 7.8% | 5.5% | 10.6% | 1.2% | β2.3% | 5.9% | 4.1% |
| Return on capital employed | 18.0% | 16.0% | 11.4% | 8.1% | 5.6% | 11.5% | 2.2% | β2.7% | 6.8% | 4.7% |
| Return on equity | 17.5% | 15.1% | 11.9% | 9.6% | 6.2% | 12.2% | 0.3% | β5.7% | 6.8% | 4.7% |
| Return on assets | 9.2% | 8.7% | 6.8% | 5.6% | 3.7% | 7.2% | 0.2% | β3.3% | 3.9% | 2.8% |
| Growth | ||||||||||
| Revenue growth | 11.0% | 5.9% | 5.2% | β0.1% | β4.2% | 17.3% | 4.8% | β5.1% | β2.7% | β0.5% |
| Net income growth | 51.2% | 4.4% | β11.3% | β13.6% | β30.7% | 100.4% | β97.6% | β1,881.8% | β | β28.1% |
| EPS growth | 50.2% | 4.0% | β11.6% | β10.2% | β29.9% | 106.9% | β97.4% | β1,907.7% | β | β26.7% |
| FCF growth | 58.2% | β57.3% | 34.6% | 125.5% | 53.9% | β52.9% | β86.0% | 709.4% | β5.1% | β9.3% |
| Share count change | 0.7% | 0.4% | β0.1% | β3.4% | β1.2% | β3.2% | β7.3% | β0.6% | β0.2% | β1.9% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.4x | 1.5x | 1.9x | 1.7x | 1.2x | 0.9x | 2.6x | 6.3x | 1.3x | 1.1x |
| Debt / equity | 0.4x | 0.4x | 0.4x | 0.3x | 0.3x | 0.3x | 0.4x | 0.4x | 0.3x | 0.3x |
| Interest coverage | 31.6x | 43.5x | 28.2x | 20.0x | 12.1x | 23.3x | 4.7x | β3.8x | 14.3x | 27.5x |
| Current ratio | 1.3x | 1.5x | 1.4x | 1.6x | 2.3x | 1.8x | 1.9x | 1.8x | 2.0x | 2.2x |
| Quick ratio | 0.7x | 0.8x | 0.7x | 0.8x | 1.5x | 1.0x | 1.0x | 1.0x | 1.1x | 1.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 7.5% | 9.6% | 8.0% | 5.5% | 4.5% | 6.0% | 5.0% | 5.5% | 4.2% | 4.1% |
| Stock comp / revenue | 0.4% | 0.4% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.3% | 0.3% |
| Payouts / FCF | 0.0% | 0.0% | 70.8% | 11.5% | 14.0% | 142.2% | 347.6% | 0.0% | 24.0% | 24.3% |
| Quality scores | ||||||||||
| Piotroski F-score | 7.0 | 8.0 | 4.0 | 6.0 | 5.0 | 8.0 | 6.0 | 4.0 | 9.0 | 7.0 |
| Altman Z'' | 4.3 | 4.6 | 4.2 | 4.6 | 4.9 | 5.0 | 4.5 | 4.1 | 5.2 | 5.2 |
| Accruals ratio | β4.1% | β2.0% | β2.5% | β5.1% | β9.1% | β1.9% | β4.5% | β12.9% | β4.7% | β5.2% |
Source: SEC EDGAR XBRL filings (CIK 0000851968). Data updated October 19, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.